SU1498, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Causes Accumulation of Phosphorylated ERK Kinases and Inhibits Their Activity in Vivo and in Vitro
Open Access
- 1 February 2004
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (7) , 5716-5724
- https://doi.org/10.1074/jbc.m308625200
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Differential interaction of the tyrosine phosphatases PTP-SL, STEP and HePTP with the mitogen-activated protein kinases ERK1/2 and p38alpha is determined by a kinase specificity sequence and influenced by reducing agentsBiochemical Journal, 2003
- Leptin Induces Endothelial Cell Migration Through Akt, Which Is Inhibited by PPARγ-LigandsHypertension, 2002
- Sphingosine 1-Phosphate, a Key Cell Signaling MoleculeJournal of Biological Chemistry, 2002
- Cooperativity between the Ras-ERK and Rho-Rho Kinase Pathways in Urokinase-type Plasminogen Activator-stimulated Cell MigrationJournal of Biological Chemistry, 2002
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- Sphingosylphosphorylcholine Induces Endothelial Cell Migration and MorphogenesisBiochemical and Biophysical Research Communications, 2000
- Serine protease inhibitor TPCK prevents Taxol-induced cell death and blocks c-Raf-1 and Bcl-2 phosphorylation in human breast carcinoma cellsOncogene, 1999
- The Effect of Cyclic Adenosine Monophosphate on the Mitogen-Activated Protein Kinase Pathway Depends on Both the Cell Type and the Type of Tyrosine Kinase-ReceptorEndocrinology, 1997
- PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in VivoJournal of Biological Chemistry, 1995
- G PROTEINS: TRANSDUCERS OF RECEPTOR-GENERATED SIGNALSAnnual Review of Biochemistry, 1987